A year after an ORI report discredited the work of former University of Washington in Seattle researcher Andrew Aprikyan, one of the papers named in the report has finally been retracted.
Here’s the notice for “Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia”: Continue reading A year after ORI report, hematology journal retracts faked paper
Another retraction has appeared up for frequent fliers Jun Li, Kailun Zhang and Jiahong Xia at Huazhong Science and Technology University in Wuhan, China.
We’ve covered them twice before, for a variety of retractions, corrections, and expressions of concern.
The retraction, in Clinical and Experimental Immunology, upgrades an expression of concern published earlier this year, and is the team’s fourth.
Here’s the notice for “CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice”: Continue reading Serial figure fakers have expression of concern upgraded to a retraction
In a stunning and tragic development, a co-author of the now-retracted Nature papers claiming to have found an easy way to create stem cells has committed suicide, according to news reports in Japan.
According to the Japan Times, RIKEN deputy director Yoshiki Sasai has died: Continue reading STAP stem cell co-author commits suicide: Reports
A 2011 paper in PLOS ONE has been retracted due to “inappropriately assembled” images. The issues, which were highlighted in a correction in TK, are attributed to the corresponding author, Paola Palozza, who has since passed away.
Here’s the notice for “Lycopene Inhibits NF-kB-Mediated IL-8 Expression and Changes Redox and PPARγ Signalling in Cigarette Smoke–Stimulated Macrophages,” which has been cited 33 times, according to Thomson Scientific’s Web of Knowledge: Continue reading PLOS ONE retraction notice blames deceased author for image manipulation
A panel reviewing The BMJ‘s handling of two controversial statin papers said the journal didn’t err when it corrected, rather than retracted, the articles.
The articles — a research paper and a commentary — suggested that use of statins in people at low risk for cardiovascular disease could be doing far more harm than good. Both articles inaccurately cited a study that provided data important to their conclusions — an error pointed out vigorously by a British researcher, Rory Collins, who demanded that the journal pull the pieces.
In a letter to Godlee this spring, Collins wrote: Continue reading Panel says BMJ was right to not retract two disputed statin papers
Another stem cell paper has been retracted from Nature, this one a highly cited 2008 study that had already been the subject of what the journal’s news section called a “furore” in 2010.
According to that 2010 news story:
The researchers behind the original work1, led by Thomas Skutella of the University of Tübingen, reported using cells from adult human testes to create pluripotent stem cells with similar properties to embryonic stem cells.
But a 2010 Brief Communication Arising called those findings into question. And now, the authors have retracted the paper. Here’s the notice for “Generation of pluripotent stem cells from adult human testis:” Continue reading Another Nature stem cell paper is retracted
A former postdoc at MD Anderson Cancer Center faked the results of a mouse study of a Novartis compound designed to fight brain tumors, according to the Office of Research Integrity (ORI).
Jun Fu “admitted to knowingly and intentionally falsifying Figure 8a” in “Novel HSP90 Inhibitor NVP-HSP990 Targets Cell-Cycle Regulators to Ablate Olig2-Positive Glioma Tumor–Initiating Cells,” a paper published in Cancer Research on May 15, 2013:
Continue reading MD Anderson postdoc faked results of Novartis anti-cancer compound study
A stumble in data preparation earned a retraction for a paper on delirium tremens
, a life-threatening side effect of alcohol withdrawal that spans a wide range of symptoms, including hallucinations and seizures.
Though the initial retraction notice was extremely unhelpful, the author stepped in to give us a better picture of the errors that led to the paper’s demise.
Here’s the notice from Alcohol and Alcoholism about “Biochemical Predictors of Delirium Tremens in Patients in Alcohol Withdrawal”:
A research team at the University of Texas-Southwestern that has retracted eight papers for image manipulation has retracted another, this one in Lung Cancer.
Here’s the notice for “Aberrant methylation of Reprimo in lung cancer,” published by Adi Gazdar’s group: Continue reading UT-Southwestern cancer research group notches ninth retraction
A group of researchers at Stanford and elsewhere is retracting a 2013 paper that another scientist told Nature was “one of the biggest things to happen in the narcolepsy field for some time.”
The Science Translational Medicine paper caused a buzz because it claimed to show that narcolepsy was an autoimmune disease. Here’s the notice: Continue reading Authors retract paper “confirming” that narcolepsy is an autoimmune disease